This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Related Videos Related Content Advertisement June 27th 2025 Chronic IVIG Therapy May Reduce Incidence of Cancer, Especially in Patients With CIDP Luke Halpern, Assistant Editor June 3rd 2025 S2.
Additionally, ANDA submissions should extrapolate the RLD safety and effectiveness data for drugs with the same active ingredients, dosage forms, strengths, routes, and labeling. In the 505(j) ANDA approval pathway, on the other hand, submissions can be multisource generic drugs; however, this pathway requires bioequivalence to the RLD.
By incorporating a patient's genetic profile into therapeutic decision-making, pharmacists can identify optimal drug choices and dosages while minimizing the risk of adverse events (AEs). This is particularly vital in polypharmacy scenarios, where the risk of drug-drug interactions and cumulative toxicity is high.
A group of experts will present an encore abstract titled " Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using Real-World Data " at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.
1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. December 21, 2004. Subscribe Now!
4 Nononcology applications are growing, however, particularly for conditions such as osteoarthritis, type 1 diabetes, and Parkinson disease. CD19-directed CAR T therapy has shown promising outcomes in systemic lupus erythematosus, prompting more than a dozen trials targeting lupus, type 1 diabetes, myasthenia gravis, and multiple sclerosis.
The investigators assessed a total of 90 patients who received talquetamab at a dosage of 0.8 mg/kg once every 2 weeks plus teclistamab at a dosage of 3.0 2 As a combination therapy, talquetamab and teclistamab show significant promise in the phase 1b/2 dose escalation and expansion in the RedirecTT-1 trial (NCT04586426).
In terms of knowledge, I generally divide the preparations into 2 key parts: Familiar yourself with common oral medications that you probably encounter in a daily basic (including both indications and dosage). You should be at least familiar with insulin and inhalers counselling before entering ward, inpatient or outpatient.
He was seeking guidance on the appropriate oral dosage for a CKD patient with creatinine clearance (CrCl) of 0.41ml/min. CrCl 30 to 80 ml/minute: No dosage adjustment necessary. Dosage A prescription of metformin at a dosage of 3 g once daily. He wanted to switch a patient from IV Augmentin to the oral form.
Based on our 2023 survey, we anticipate a significant increase in the adoption of pharmacy-provided services such as diagnostic services, health screenings, home delivery of medicine, and medication therapy management for chronic illnesses such as hypertension and diabetes (see Fig 4).
When the sample concentration is subtherapeutic yet patient is responding well, is dosage adjustment necessary? Post dosage adjustment of sodium valproate, how long should we wait at least prior to TDM reassessment? Can metformin be continued in diabetes during pregnancy ? Explain on auto-induction of carbamazepine.
One study found increased obsessive-compulsive symptoms in men with type 1 diabetes. Another found that OCD patients had a higher risk of developing type 2 diabetes. Obsessive-compulsive symptoms were also found to be positively correlated with blood levels of HbA1c, a commonly used diagnostic measure of type 2 diabetes.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content